Triglyceride-lowering trial neutral for cardiovascular event reduction brighamwomens nejm
through an institution grant to the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital.This article was published on November 5, 2022, at NEJM.org.Author Affiliations
From the Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and the Division of Cardiovascular Medicine , Brigham and Women’s Hospital, the Division of Cardiovascular Medicine, Veteran Affairs Boston Health Care System , and Kowa Pharma Development — all in Boston; University of Lille, Lille and the Department of Neurology and Stroke Center, Paris Cité University, Paris — both in France; Kowa Research Institute, Morrisville, NC ; the Division of Lipidology,...
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Olaf Scholz leads a blue-chip business delegation to ChinaGerman industry has been strangely reluctant to reduce its dependence
Læs mere »
The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis - MicrobiomeBackground The role of the pulmonary microbiome in sarcoidosis is unknown. The objectives of this study were the following: (1) examine whether the pulmonary fungal and bacterial microbiota differed in patients with sarcoidosis compared with controls; (2) examine whether there was an association between the microbiota and levels of the antimicrobial peptides (AMPs) in protected bronchoalveolar lavage (PBAL). Methods Thirty-five sarcoidosis patients and 35 healthy controls underwent bronchoscopy and were sampled with oral wash (OW), protected BAL (PBAL), and left protected sterile brushes (LPSB). The fungal ITS1 region and the V3V4 region of the bacterial 16S rRNA gene were sequenced. Bioinformatic analyses were performed with QIIME 2. The AMPs secretory leucocyte protease inhibitor (SLPI) and human beta defensins 1 and 2 (hBD-1 and hBD-2), were measured in PBAL by enzyme-linked immunosorbent assay (ELISA). Results Aspergillus dominated the PBAL samples in sarcoidosis. Differences in bacterial taxonomy were minor. There was no significant difference in fungal alpha diversity between sarcoidosis and controls, but the bacterial alpha diversity in sarcoidosis was significantly lower in OW (p=0.047) and PBAL (p=0.03) compared with controls. The beta diversity for sarcoidosis compared with controls differed for both fungi and bacteria. AMP levels were significantly lower in sarcoidosis compared to controls (SLPI and hBD-1: p | 0.01). No significant correlations were found between alpha diversity and AMPs. Conclusions The pulmonary fungal and bacterial microbiota in sarcoidosis differed from in controls. Lower antimicrobial peptides levels were seen in sarcoidosis, indicating an interaction between the microbiota and the innate immune system. Whether this dysbiosis represents a pathogenic mechanism in sarcoidosis needs to be confirmed in experimental studies. Video Abstract
Læs mere »
I'm A Celebrity's Jungle VIPs unveiled with island twist ahead of first TrialI'm a Celebrity... Get Me Out of Here!'s Jungle VIPs were revealed on Sunday's first episode and the four stars will 'rough it' on a deserted island ahead of the first Trial
Læs mere »
What to watch ahead of the midtermsIf, as expected, Republicans win the House and possibly take control of the Senate, American politics could descend into partisan paralysis until at least 2024
Læs mere »
Collapsing chains are forcing property buyers out of the market in favour of lower bidsSales of homes are starting to collapse, so much so, sellers are now swerving buyers in a chain altogether – even if it means they get less money 🔴 lauriehavelock
Læs mere »
Lower price, lower temperature? Sony Xperia 5 IV reviewLooking for a compact phone with flagship frills? The Xperia 5 IV is a strong contender
Læs mere »